Advisory Alpha, LLC Alkermes Plc. Transaction History

Advisory Alpha, LLC

  • $2.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$15.39 - $22.1 $1,539 - $2,210
-100 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$16.16 - $20.66 $1,616 - $2,066
100 New
100 $2,000
Q2 2020

Aug 14, 2020
SELL
$13.31 - $19.41 $1,331 - $1,941
-100 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$19.51 - $24.28 $1,951 - $2,428
100 New
100 $1,000

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.9B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Advisory Alpha, LLC Portfolio

Follow Advisory Alpha, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Alpha, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email